Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

LTI 03

Next Previous
Drug Profile

LTI 03

Alternative Names: Caveolin-1 scaffold protein-derived 7-amino acid peptide; Caveolin-1 scaffolding protein derived peptide; CSP7; LTI-03

Latest Information Update: 21 May 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Lung Therapeutics; University of Texas at Tyler
  • Developer Rein Therapeutics
  • Class Antifibrotics; Peptides
  • Mechanism of Action Caveolin 1 replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Idiopathic pulmonary fibrosis
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Idiopathic pulmonary fibrosis

Most Recent Events

  • 02 May 2025 Phase-II clinical trials in Idiopathic pulmonary fibrosis in Poland, Austria, Germany, USA, United Kingdom (Inhalation) (NCT06968845)
  • 07 Mar 2025 Rein Therapeutics has patents pending for LTI 03 in the US and outside US
  • 07 Mar 2025 Rein Therapeutics has patents protection for LTI 03 in the US and outside US

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top